Tvardi Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)

38 filings reported holding CARA - Tvardi Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Tvardi Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.08M shares of 9.36M outstanding shares and own 11.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (168K shares), Rockefeller Capital Management L.P. (156K shares), FARALLON CAPITAL MANAGEMENT LLC (130K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (118K shares), RENAISSANCE TECHNOLOGIES LLC (94K shares), Shay Capital LLC (85.7K shares), TWO SIGMA ADVISERS, LP (64.2K shares), BlackRock, Inc. (61.9K shares), Curi RMB Capital, LLC (45.3K shares), and MILLENNIUM MANAGEMENT LLC (39.4K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.